About tt

This author has not yet filled in any details.
So far tt has created 9 blog entries.
5 09, 2019

Towards a first precision medicine Immunotherapy for the treatment of Type 1 Diabetes using Ariana’s Artificial Intelligence

2019-10-02T17:17:50+00:00September 5th, 2019|

Ariana’s KEM® Artificial Intelligence technology identified immunological changes, which are early indicators of clinical effects, for selected groups of patients in a first-in-human Phase 1b study. The potential for a selection biomarker in patients receiving this therapy transforms design options for Imcyse’s future clinical trials in T1D and additional indications. […]

20 06, 2019

Appointment of Federico Goodsaid, PhD to the position of Senior Vice President for Regulatory Affairs

2019-06-20T21:54:59+00:00June 20th, 2019|

Ariana® Pharma announces the appointment of Federico Goodsaid, PhD to the position of Senior Vice President for Regulatory Affairs Paris, France and Cambridge,MA – June 18, 2019 – Ariana Pharma (Paris, France and Cambridge, MA), a leading digital health company focused on developing advanced Artificial Intelligence technologies for patient stratification in clinical trials, today announced the appointment of Federico Goodsaid, PhD, to the position of Senior Vice President for Regulatory Affairs. Federico Goodsaid’s appointment as the Senior VP Regulatory Affairs reinforces Ariana’s capability to combine its data analytics technology with regulatory expertise and to translate the findings generated by its Artificial Intelligence platform into innovative [...]